Company
Headquarters: Mauguio, France
Employees: 128
CEO: Mr. Jean-Paul Ansel
€19.3 Million
EUR as of March 1, 2022
US$21.5 Million
| Company | Market Cap (USD) |
|---|---|
| Abbott | $192.67 B |
| Stryker Corporation | $113.24 B |
| Medtronic | $111.60 B |
| Boston Scientific Corporation | $85.22 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Diagnostic Medical Systems S.A. operates in the medical imaging industry in France. It offers radiography/fluoroscopy, retrofit kits, mammography, chest and bone rooms, mobiles, bone densitometry, 3D reconstruction, mobile C-arms, and posturology solutions. The company also exports its products. Diagnostic Medical Systems S.A. was founded in 1979 and is based in Mauguio, France.
Top 1-year algo backtest: +298.72%
$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Diagnostic Medical Systems-Pais has the following listings and related stock indices.
Stock: Euronext: DGM wb_incandescent